University of Calgary

Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language (2018) Blok LS, Rousseau J, Twist J, Ehresmann S, Takaku M, Venselaar H, Rodan LH, et al. Journal article Review: The international consensus classification of Focal Cortical Dysplasia - a critical update 2018 (2018) Najm IM, Sarnat HB, Blümcke I Journal article, Review article Beta, gamma band, and high-frequency coherence of EMGs of vasti muscles caused by clustering of motor units (2018) von Tscharner V, Ullrich M, Mohr M, Comaduran Marquez D, Nigg BM Journal article Disorganized attachment in infancy: a review of the phenomenon and its implications for clinicians and policy-makers. (2017) Granqvist P, Sroufe LA, Dozier M, Hesse E, Steele M, Van Ijzendoorn M, Solomon J, et al. Journal article, Original article The SPECTRA Collaboration OMERACT Special Interest Group: Current research and future directions (2017) Stok KS, Finzel S, Burghardt AJ, Conaghan PG, Barnabe C Journal article Developing a Customized Perfusion Bioreactor Prototype with Controlled Positional Variability in Oxygen Partial Pressure for Bone and Cartilage Tissue Engineering (2017) Lee PS, Eckert H, Hess R, Gelinsky M, Rancourt D, Krawetz R, Cuniberti G, Scharnweber D Journal article Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency (2017) Lovric S, Goncalves S, Gee HY, Oskouian B, Srinivas H, Choi WI, Shril S, et al. Journal article History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium (2017) Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, et al. Journal article Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017) Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al. Journal article